Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Rapid Impact Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Metabolism Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Spotlight on Genomic Analysis of Rare and Understudied Cancers
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Research
Molecular Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Rapid Impact Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Metabolism Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Spotlight on Genomic Analysis of Rare and Understudied Cancers
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

RAS Collection

2015 RAS Collection
Molecular Cancer Research is proud to present this selection of recently published RAS articles.


  • Biochemical and structural analysis of common cancer-associated KRAS mutations.
    Hunter JC, Manandhar A, Carrasco MA, Gurbani D, Gondi S, Westover KD Molecular Cancer Research 2015. DOI:10.1158/1541-7786. MCR-15-0203. [Published OnlineFirst June 2, 2015]
  • The key role of calmodulin in KRAS-driven adenocarcinomas.
    Nussinov R, Muratcioglu S, Tsai CJ, Jang H, Gursoy A, Keskin O. Molecular Cancer Research 2015. DOI:10.1158/1541-7786.MCR-15-0165. [Published OnlineFirst June 17, 2015].
  • Colorectal carcinogenesis: connecting K-RAS–induced transformation and CREB activity in vitro and in vivo.
    Steven A, Heiduk M, Recktenwald CB, Hiebl B, Wickenhauser C, Massa C, et al. Molecular Cancer Research 2015;13:1248–62.
  • AKT1 E17K in colorectal carcinoma is associated with BRAF V600E but not MSI-H status: a clinicopathologic comparison to PIK3CA helical and kinase domain mutants.
    Hechtman JF, Sadowska J, Huse JT, Borsu L, Yaeger R, Shia J, et al. Molecular Cancer Research 2015;13:1003–8.
  • Detection of tumor suppressor genes in cancer development by a novel shRNA-based method.
    von Burstin J, Diersch S, Schneider G, Reichert M, Rustgi AK, Schmid RM. Molecular Cancer Research 2015;13:863–9.
  • The RAS–membrane interface: isoform-specific differences in the catalytic domain.
    Parker JA, Mattos C. Molecular Cancer Research 2015;13:595–603.
  • Reversal of mutant KRAS-mediated apoptosis resistance by concurrent noxa/bik induction and Bcl-2/Bcl-xL antagonism in colon cancer cells.
    Okamoto K, Zaanan A, Kawakami H, Huang S, Sinicrope FA. Molecular Cancer Research 2015;13:659–69.
  • Adapting a drug screening platform to discover associations of molecular targeted radiosensitizers with genomic biomarkers.
    Liu Q, Wang M, Kern AM, Khaled S, Han J, Yeap BY, et al. Molecular Cancer Research 2015;13:713–20.
  • Loss of keratinocytic RXRα combined with activated CDK4 or oncogenic NRAS generates UVB-induced melanomas via loss of p53 and PTEN in the tumor microenvironment.
    Coleman DJ, Chagani S, Hyter S, Sherman AM, Löhr CV, Liang X, et al. Molecular Cancer Research 2015;13:186–96.

Molecular Cancer Research Editorial Office
American Association for Cancer Research  |  Publications Division
615 Chestnut Street  |  17th Floor  |  Philadelphia, PA 19106-4404
Phone: (215) 440-9300  |  Fax: (215) 440-9411  |  E-mail:  mcr@aacr.org

  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Rapid Impact Archive
  • Meeting Abstracts

Information for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCR

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Research
eISSN: 1557-3125
ISSN: 1541-7786

Advertisement